Search

everythinglearnresearchcommunity

for

Search:↓

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

People with chronic Alopecia Areata often have lower vitamin D levels.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Systemic corticosteroids don't prevent severe alopecia areata from spreading or relapsing.

Alopecia areata has a high chance of persisting and relapsing, with a significant risk of total hair loss, especially if it starts in childhood.

Combining nonablative fractional laser with minoxidil was effective for alopecia areata with only one patient relapsing after a year.

A patient with granuloma annulare experienced both isotopic and isomorphic responses, with skin lesions responding to steroids but relapsing after stopping treatment.

Dimethyl-fumarate may cause temporary hair loss.

Hair thinning is a common but generally mild and reversible side effect of teriflunomide in multiple sclerosis patients.

Systemic corticosteroids might help treat hair loss caused by alemtuzumab in MS patients.

Cutaneous lupus erythematosus is a chronic skin disease that can progress to systemic lupus in some cases and requires treatment to prevent recurrences and scarring.

A rare skin condition causing scarring was successfully treated with topical erythromycin and benzoyl peroxide.

Erosive pustular dermatosis is a rare skin disease that's hard to treat and affects the scalp or legs.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

The document talks about hard-to-treat and rare acne types, their connection with other health issues, the importance of correct diagnosis, and the challenges in managing them.

A patient had both chronic cutaneous lupus erythematosus and frontal fibrosing alopecia.

Eyebrow reconstruction using hair follicle grafts was successful in a man with a benign hereditary disorder affecting his eyebrows.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

MS patients often have skin issues, so regular skin checks are important.

Baricitinib is a promising treatment for alopecia areata.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Oral isotretinoin is the most effective treatment for folliculitis decalvans.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

The document concludes that syphilis has varied symptoms that are often missed, making clinical awareness crucial for diagnosis.